Volitionrx (VNRX) Interest & Investment Income (2019 - 2025)
Volitionrx (VNRX) posted Interest & Investment Income of $122.0 for Q4 2025, down 23.75% on a QoQ basis from $160.0 in Q3 2025, and down 61.02% year-over-year from $313.0 in Q4 2024.
Volitionrx (VNRX) Interest & Investment Income (2019 - 2025) Analysis & Trends
Volitionrx's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $122.0 for Q4 2025.
- Quarterly Interest & Investment Income fell 61.02% year-over-year to $122.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $600.0 (down 93.97% YoY) and the FY2025 annual result came in at $600.0, down 93.97% from the prior year.
- Interest & Investment Income was $122.0 for Q4 2025 at Volitionrx, down from $160.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $67157.0 in Q4 2022 and bottomed at $2.0 in Q1 2022.
- A 5-year average of $11593.5 and a median of $471.0 in 2021 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income plunged 99.88% — and 2023, when it soared 2882300.0%.
- Volitionrx's Interest & Investment Income stood at $231.0 in 2021, then surged by 28972.29% to $67157.0 in 2022, then tumbled by 87.59% to $8337.0 in 2023, then slumped by 96.25% to $313.0 in 2024, then plunged by 61.02% to $122.0 in 2025.
- Business Quant data shows VNRX's Interest & Investment Income at $122.0 in Q4 2025, $160.0 in Q3 2025, and $160.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Volitionrx | 89,525.10 | -1.03 Mn | - | 122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122.00 |
| Sep 30, 2025 | 160.00 |
| Jun 30, 2025 | 160.00 |
| Mar 31, 2025 | 158.00 |
| Dec 31, 2024 | 313.00 |
| Sep 30, 2024 | 530.00 |
| Jun 30, 2024 | 450.00 |
| Mar 31, 2024 | 8,654.00 |
| Dec 31, 2023 | 8,337.00 |
| Sep 30, 2023 | 230.00 |
| Jun 30, 2023 | 27,109.00 |
| Mar 31, 2023 | 57,648.00 |
| Dec 31, 2022 | 67,157.00 |
| Sep 30, 2022 | 46,945.00 |
| Jun 30, 2022 | 11,161.00 |
| Mar 31, 2022 | 2.00 |
| Dec 31, 2021 | 231.00 |
| Sep 30, 2021 | 290.00 |
| Jun 30, 2021 | 492.00 |
| Mar 31, 2021 | 1,721.00 |